Guangzhou Human New Material Science and Technology Co Ltd

Guangzhou Human New Material Science and Technology Co Ltd maintains a strong liquidity position, with a current ratio of 3.93, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its debt-to-equity ratio of 0.08, indicating a relatively low reliance on debt financing. In terms of profitability, the company's return on equity (ROE) of 17.41% and return on assets (ROA) of 14% are strong, suggesting efficient use of equity and assets to generate profit. These metrics are well above the typical thresholds for the Commodity Chemicals industry, indicating a competitive performance in terms of returns. The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking at the growth trajectory, the company's revenue and net income have shown positive trends, with a net income of 206.79 million CNY and revenue of 985.18 million CNY in the latest reporting period. However, the outlook for the next fiscal year is not explicitly provided, and the company's capital expenditure of -87.05 million CNY suggests a reduction in investment in new projects or facilities. The risk assessment indicates a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. However, the company's negative net cash position after debt is a key flag that could affect its financial stability. The company has not disclosed any recent events such as filings or transcripts that would provide additional insight into its operations or strategic direction.